Aniracetam

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Aniracetam
IUPAC name 1-[(4-methoxybenzoyl)]- 2-pyrrolidinone
Identifiers
CAS number 72432-10-1
PubChem 2196
SMILES COC1=CC=C(C=C1)C(=O)N2CCCC2=O
Properties
Molecular formula C12H13NO3
Molar mass 219.237
Pharmacology
Bioavailability ~100%
Routes of
administration
Oral and parenteral
Elimination
half-life
4 - 5 hr
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)

Infobox disclaimer and references

Aniracetam (Draganon®, Sarpul®, Ampamet®) is a nootropic drug of the racetam family purported to be considerably more potent than piracetam. It is lipid soluble and has possible cognition enhancing effects. It has been tested in animals extensively, Alzheimer's patients and temporarily-impaired healthy subjects, but has not been tested in healthy, unimpaired humans. It has shown potential as an anxiolytic in three clinical animal models.

Contents

Pharmacology

After a confirmed test of the anxiolytic efficacy in a mouse model, receptor antagonists haloperidol, mecamylamine, and ketanserin were applied. Haloperidol completely reversed the anxiolytic effects, and mecamylamine and ketanserin nearly completely reversed the effects. This shows that aniracetam's anxiolytic mechanism is facilitated by D2/D3 dopamine, nicotinic acetylcholine, and 5-HT2A receptors[1].

See also

External links

References


de:Aniracetam

ko:애니라세탐

Personal tools